000 01369 a2200385 4500
005 20250514062354.0
264 0 _c20030801
008 200308s 0 0 eng d
022 _a0271-0749
024 7 _a10.1097/00004714-200304000-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHwang, Jen-Ping
245 0 0 _aThe efficacy and safety of olanzapine for the treatment of geriatric psychosis.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cApr 2003
300 _a113-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntipsychotic Agents
_xadministration & dosage
650 0 4 _aBenzodiazepines
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOlanzapine
650 0 4 _aPirenzepine
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aYang, Cheng-Hung
700 1 _aLee, Tien-Wen
700 1 _aTsai, Shih-Jen
773 0 _tJournal of clinical psychopharmacology
_gvol. 23
_gno. 2
_gp. 113-8
856 4 0 _uhttps://doi.org/10.1097/00004714-200304000-00002
_zAvailable from publisher's website
999 _c12434598
_d12434598